Strains and methods useful for mycotoxins
AssigneeDupont Nutrition Biosciences Aps
InventorsMari Ellen Davis, Joshua Rehberger, Kimberly Novak, Thomas G. Rehberger
Life of this patent
Estimating the term…
Abstract
The disclosure relates to strains, compositions and methods for detoxifying a mycotoxin. In another embodiment, the disclosure relates to strains, compositions and methods for alleviating the gastrointestinal inflammatory response resulting from ingestion of mycotoxins. In one embodiment, the strains are Bacillus strains. In another embodiment, the strains are lactic acid bacteria.
Claims21
An isolated Bacillus strain wherein the Bacillus strain is selected from the group consisting of B. licheniforms 3-12a (NRRL B-50504), B. subtilis 4-7d (NRRL B-50505), B. licheniformis 4-2a (NRRL B-50506), and B. subtilis 3-5h (NRRL B-50507), strains having all the characteristics thereof, any derivative or variant thereof, and mixtures thereof.
An isolated strain capable of alleviating a gastrointestinal inflammatory response when the strain is administered to an animal, wherein the strain is a lactic acid bacteria strain or a Bacillus strain.
A composition comprising supernatant from one or more culture(s) of one or more strain(s) capable of alleviating a gastrointestinal inflammatory response when the strain is administered to an animal, wherein the strain is a lactic acid bacteria strain or a Bacillus strain.
A composition comprising Lactobacillus brevis 1E-1 (ATCC PTA-6509) and one or more strain(s) selected from the group consisting of B. licheniformis 3-12a (NRRL B-6b 50504), B. subtilis 4-7d (NRRL B-50505), B. licheniformis 4-2a NRRL B-50506), and B. subtilis 3-5h (NRRL B-50507), L. johnsonii PLC B6 (NRRL B-50518), Enterococcus faecium 2-1d (NRRL B-50519), strains having all the characteristics thereof, any derivative or variant thereof, and mixtures thereof.
Dependencies are inferred from the claim text.